v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities:    
Net loss $ (487,291) $ (727,882)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 136,234 103,641
Non-cash operating lease costs 35,551 33,998
Amortization of deferred commissions 117,473 58,954
Stock-based compensation, net of any amounts capitalized 826,052 783,677
Net accretion of discounts on investments (3,286) (13,369)
Net realized and unrealized losses (gains) on strategic investments (25,257) 35,265
Amortization of debt issuance costs 4,161 4,145
Asset impairment related to office facility exits 17,836 108,619
Deferred income tax (8,489) (3,445)
Other 7,355 (3,489)
Changes in operating assets and liabilities, net of effects of business combinations:    
Accounts receivable 600,630 276,051
Deferred commissions (106,320) (84,864)
Prepaid expenses and other assets (351) (22,338)
Accounts payable 41,231 7,348
Accrued expenses and other liabilities 28,056 97,226
Operating lease liabilities (41,842) (26,397)
Deferred revenue (807,163) (323,871)
Net cash provided by operating activities 334,580 303,269
Cash flows from investing activities:    
Purchases of property and equipment (18,005) (61,654)
Cash paid for business combinations, net of cash, cash equivalents and restricted cash acquired (254,449) (164,230)
Purchases of intangible assets 0 (1,311)
Purchases of investments (1,816,116) (1,649,044)
Sales of investments 238,456 18,875
Maturities and redemptions of investments 896,186 1,502,129
Net cash used in investing activities (953,928) (355,235)
Cash flows from financing activities:    
Proceeds from exercise of stock options 74,424 34,446
Proceeds from issuance of common stock under employee stock purchase plan 66,987 53,193
Taxes paid related to net share settlement of equity awards (327,742) (294,497)
Repurchases of common stock (300,003) (490,638)
Payments of deferred purchase consideration for business combinations (2,250) (600)
Net cash used in financing activities (488,584) (698,096)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (4,684) 12,222
Net decrease in cash, cash equivalents, and restricted cash (1,112,616) (737,840)
Cash, cash equivalents, and restricted cash—beginning of period 2,864,303 2,698,678
Cash, cash equivalents, and restricted cash—end of period 1,751,687 1,960,838
Supplemental disclosures of non-cash investing and financing activities:    
Property and equipment included in accounts payable and accrued expenses 9,545 35,392
Non-cash consideration for business combinations 420,590 0
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 1,707,187 1,880,720
Restricted cash—included in other assets and prepaid expenses and other current assets 44,500 80,118
Total cash, cash equivalents, and restricted cash $ 1,751,687 $ 1,960,838